Bay-Jensen AC - Search Results

1

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease.

Bourgonje AR, Alexdottir MS, Otten AT, Loveikyte R, Bay-Jensen AC, Pehrsson M, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, Karsdal MA, Faber KN, Mortensen JH, Dijkstra G. Bourgonje AR, et al. Aliment Pharmacol Ther. 2022 Aug;56(4):675-693. doi: 10.1111/apt.17063. Epub 2022 Jun 6. Aliment Pharmacol Ther. 2022. PMID: 35661188 Free PMC article.

2

The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?

Qvist P, Bay-Jensen AC, Christiansen C, Dam EB, Pastoureau P, Karsdal MA. Qvist P, et al. Pharmacol Res. 2008 Jul;58(1):1-7. doi: 10.1016/j.phrs.2008.06.001. Epub 2008 Jun 8. Pharmacol Res. 2008. PMID: 18590824 Review.

3

Biochemical markers of joint tissue turnover.

Bay-Jensen AC, Sondergaard BC, Christiansen C, Karsdal MA, Madsen SH, Qvist P. Bay-Jensen AC, et al. Assay Drug Dev Technol. 2010 Feb;8(1):118-24. doi: 10.1089/adt.2009.0199. Assay Drug Dev Technol. 2010. PMID: 19715454 Review.

4

Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis?

Bay-Jensen AC, Hoegh-Madsen S, Dam E, Henriksen K, Sondergaard BC, Pastoureau P, Qvist P, Karsdal MA. Bay-Jensen AC, et al. Rheumatol Int. 2010 Feb;30(4):435-42. doi: 10.1007/s00296-009-1183-1. Epub 2009 Oct 9. Rheumatol Int. 2010. PMID: 19816688 Review.

5

Aggrecanase- and matrix metalloproteinase-mediated aggrecan degradation is associated with different molecular characteristics of aggrecan and separated in time ex vivo.

Madsen SH, Sumer EU, Bay-Jensen AC, Sondergaard BC, Qvist P, Karsdal MA. Madsen SH, et al. Biomarkers. 2010 May;15(3):266-76. doi: 10.3109/13547500903521810. Biomarkers. 2010. PMID: 20039789

6

Application of biochemical markers in development of drugs for treatment of osteoarthritis.

Qvist P, Christiansen C, Karsdal MA, Madsen SH, Sondergaard BC, Bay-Jensen AC. Qvist P, et al. Biomarkers. 2010 Feb;15(1):1-19. doi: 10.3109/13547500903295873. Biomarkers. 2010. PMID: 20085489 Review.

7

Serum markers of liver fibrosis: combining the BIPED classification and the neo-epitope approach in the development of new biomarkers.

Veidal SS, Bay-Jensen AC, Tougas G, Karsdal MA, Vainer B. Veidal SS, et al. Dis Markers. 2010;28(1):15-28. doi: 10.3233/DMA-2010-0678. Dis Markers. 2010. PMID: 20164543 Free PMC article. Review.

8

Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats.

Veidal SS, Vassiliadis E, Bay-Jensen AC, Tougas G, Vainer B, Karsdal MA. Veidal SS, et al. Fibrogenesis Tissue Repair. 2010 Apr 1;3(1):5. doi: 10.1186/1755-1536-3-5. Fibrogenesis Tissue Repair. 2010. PMID: 20359335 Free PMC article.

9

Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes.

Sondergaard BC, Madsen SH, Segovia-Silvestre T, Paulsen SJ, Christiansen T, Pedersen C, Bay-Jensen AC, Karsdal MA. Sondergaard BC, et al. BMC Musculoskelet Disord. 2010 Apr 5;11:62. doi: 10.1186/1471-2474-11-62. BMC Musculoskelet Disord. 2010. PMID: 20367884 Free PMC article.

10

Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers--are they the cause or the consequence of the disease?

Karsdal MA, Henriksen K, Leeming DJ, Woodworth T, Vassiliadis E, Bay-Jensen AC. Karsdal MA, et al. Clin Biochem. 2010 Jul;43(10-11):793-804. doi: 10.1016/j.clinbiochem.2010.03.015. Epub 2010 Apr 8. Clin Biochem. 2010. PMID: 20381482 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

255 results

Search Page